NCT04422587View on ClinicalTrials.gov

Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea

CompletedOBSERVATIONAL
Enrollment

1,860

Participants

Timeline

Start Date

March 13, 2020

Primary Completion Date

June 5, 2020

Study Completion Date

June 7, 2020

Conditions
Emergencies
Interventions
OTHER

RECOP unit patient

All patients admit in RECOP unit for dyspnea can be included in this study if patient is agree. Then, doctor collects demographic variables, the usual history and treatments, the characteristics of the episode (symptomatology, evolution, treatment taken) and the data from the initial clinical examination will be identified.

Trial Locations (1)

31000

University Hospital of Toulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT04422587 - Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea | Biotech Hunter | Biotech Hunter